• About
  • Contact
Tuesday, May 13, 2025
No Result
View All Result
Londoner News
  • Home
  • London
  • Britain
  • Europe
  • America
  • International
  • Submit Article
  • Other
    • Health
    • Tech
    • Travel
    • Science
  • Home
  • London
  • Britain
  • Europe
  • America
  • International
  • Submit Article
  • Other
    • Health
    • Tech
    • Travel
    • Science
No Result
View All Result
Londoner News
No Result
View All Result
Home Markets

CCI approves P&G’s stake acquisition in Merck

by The Editor
August 7, 2018
in Markets
0
CCI approves P&G’s stake acquisition in Merck
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

NEW DELHI: The Competition Commission has approved Procter & Gamble's acquisition of 51.80 per cent stake in drug firm Merck Ltd, which is listed on the Indian bourses. The acquisition of 51.80 per cent stake in Merck Ltd by P&G for nearly Rs 1,290 crore is part of a global deal under which the latter is taking over German firm Merck KGaA's international consumer health business.

The global deal is for about 3.4 billion euro in cash.

In a tweet today, the Competition Commission of India (CCI) said it has approved acquisition of 51.80 per cent stake by P&G in consumer health business of Merck Ltd.

The stake acquisition will be through Procter & Gamble Overseas India BV, an investment holding company held ultimately by P&G.

According to the notice submitted to the CCI, P&G had proposed to acquire the consumer health business of Merck KGaA globally, pursuant to a sale and purchase agreement dated April 19, 2018 (Global SAPA). As part of the agreement, P&G had also offered to buy the consumer health business of Merck Specialities.

Separately, following another sale and purchase agreement dated April 19, 2018 (India SAPA), Procter & Gamble Overseas India BV had proposed to acquire 51.80 per cent shares in Merck Ltd, as per the notice.

The global deal will be executed through the sale of Merck's shares in a number of legal entities as well as various asset sales and comprises the consumer health business across 44 countries, including more than 900 products and two consumer health-managed production sites in Spittal (Austria) and Goa (India).

The transaction is expected to close by the year end. JP Morgan acted as financial adviser to Merck on the transaction, while Freshfields Bruckhaus Deringer acted as its legal adviser.

The Competition Commission has also approved Singapore-based investment fund TPG Asia VII SF's stake acquisition in RR Kabel and Ram Ratna Electricals.

"@CCI_India approves acquisition of ~21 per cent stake in each RR Kabel and Ram Ratna Electricals by TPG Asia," the CCI said in a tweet.

RR Kabel manufactures wires and cables while Ram Ratna Electricals is the consumer electricals and appliances arm of RR Global Group.

Original Article

[contf] [contfnew]

ET Markets

[contfnewc] [contfnewc]

The Editor

Next Post
Adani Transmission PAT doubles to Rs 169 crore in Q1

Adani Transmission PAT doubles to Rs 169 crore in Q1

Recommended

Stocks in focus on May 4, 2018

Stocks in focus on May 4, 2018

7 years ago
Iran protests: Reports of violence on third day of demonstrations

Iran protests: Reports of violence on third day of demonstrations

7 years ago

Popular News

    Connect with us

    About Us

    We bring you the best Premium WordPress Themes that perfect for news, magazine, personal blog, etc. Check our landing page for details.

    Category

    • America
    • Britain
    • Entertainment
    • Europe
    • Health
    • International
    • latest news
    • London
    • Markets
    • Science
    • Tech
    • Travel
    • Uncategorized
    • Women

    Site Links

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • About
    • Contact

    © 2020 londonernews

    No Result
    View All Result
    • Home
    • Science
    • Travel
    • Tech
    • Health

    © 2020 londonernews